Acadia Healthcare (NASDAQ:ACHC) Releases Earnings Results, Beats Expectations By $0.05 EPS

Acadia Healthcare (NASDAQ:ACHC) announced its earnings results on Monday. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.05, Zacks reports. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s revenue for the quarter was up .3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.84 EPS. Acadia Healthcare updated its FY 2025 guidance to 2.500-2.800 EPS.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $26.94 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.48 billion, a PE ratio of 8.83, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. Acadia Healthcare has a twelve month low of $20.36 and a twelve month high of $82.41. The stock’s 50-day simple moving average is $26.43 and its 200 day simple moving average is $36.08.

Wall Street Analyst Weigh In

Several brokerages recently commented on ACHC. Barclays cut Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $43.00 to $35.00 in a research report on Friday, February 28th. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Mizuho cut their price objective on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research report on Tuesday, March 25th. Guggenheim began coverage on Acadia Healthcare in a report on Wednesday, April 9th. They set a “buy” rating and a $36.00 target price on the stock. Finally, Bank of America reduced their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $50.39.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.